Clinical Trial Update: Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating Ameluz in combination with the BBL HEROic device for actinic keratosis and photodamage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Photodamage

Drugs mentioned

• AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

Sponsor: Sherrif Ibrahim | Conditions: Actinic Keratoses, Photodamage | Phase 1 | Status: COMPLETED